Joris H. Robben

The Succinate Receptor as a Novel Therapeutic Target for Oxidative and Metabolic Stress-Related Conditions

Ana Carolina Ariza, Peter Meinardus T. Deen, Joris H. Robben · Frontiers in Endocrinology · 2012 · 202 citations · Full text

Lipid Peroxidation, Immunology, Novel Therapeutic Target +23

SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes

Janna A. van Diepen, Joris H. Robben, Guido Hooiveld et al. · Diabetologia · 2017 · 170 citations · Full text

SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway

Simon T. Cliffe, Jamie M. Kramer, Khalid Hussain et al. · Human Molecular Genetics · 2009 · 117 citations

Metabolic Syndrome, Insulin Signaling, Genetic Disorder +15

Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus

Joris H. Robben, Mozes Sze, Nine V.A.M. Knoers et al. · American Journal of Physiology-Renal Physiology · 2006 · 117 citations · Full text

Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells

Joris H. Robben, Robert A. Fenton, Sarah Vargas et al. · Kidney International · 2009 · 112 citations · Full text

Succinate Receptor, Molecular Physiology, Signal Transduction +8